Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miiiome Technology is a Singapore-based biotechnology company specializing in the development of advanced microbiome-based therapeutics and skin health solutions. Utilizing a proprietary synthetic biology platform, the company engineers beneficial microbes to restore balance to the human microbiome and combat pathogenic bacteria. Their primary focus is on dermatological applications, including treatments for atopic dermatitis and other skin-related conditions. Miiiome aims to provide precision-engineered microbial therapies that offer safer and more effective alternatives to traditional antibiotics and topical treatments. The company is a spin-off from the National University of Singapore, leveraging cutting-edge research in microbial engineering to address unmet needs in skin care and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miiiome Technology.